|Bid||8.82 x 1300|
|Ask||13.80 x 900|
|Day's Range||12.17 - 13.13|
|52 Week Range||4.96 - 19.32|
|Beta (5Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 01, 2022 - Mar 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.75|
NEW YORK, January 06, 2022--Iveric Bio announced today the election of Christine Ann Miller to its Board of Directors, effective immediately.
NEW YORK, January 04, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.
NEW YORK, January 04, 2022--Iveric Bio will participate in the H.C. Wainwright BioConnect Virtual Conference, being held virtually from January 10-13, 2022.